GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GridAI Technologies Corp. (GRDX) | 9/18/2026 6:15:25 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2026 ending: 6/30/2026 | Assets $37,035,600 | EPS -$2.01 | ||
| GridAI Technologies Corp. (GRDX) | 8/21/2026 5:34:46 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $37,035,600 | EPS -$2.01 | ||
| GridAI Technologies Corp. (GRDX) | 5/27/2026 6:13:21 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $38,208 | Assets $47,965,678 | EPS -$0.82 | |
| GridAI Technologies Corp. (GRDX) | 5/1/2026 4:11:38 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $36,251 | Assets $48,551,843 | EPS -$4.16 | |
| Entero Therapeutics, Inc. (GRDX) | 11/19/2025 5:26:14 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $135,370,340 | EPS -$0.75 | ||
| Entero Therapeutics, Inc. (GRDX) | 8/14/2025 11:05:43 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $85,058,951 | EPS -$0.21 | ||
| Entero Therapeutics, Inc. (GRDX) | 6/4/2025 4:07:53 PM | View | Proxy | SEC | Y 2024 | ||||||
| Entero Therapeutics, Inc. (GRDX) | 5/15/2025 1:32:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $85,203,539 | EPS -$0.28 | ||
| Entero Therapeutics, Inc. (GRDX) | 4/9/2025 5:35:37 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Assets $85,409,506 | EPS -$5.33 | ||
| Entero Therapeutics, Inc. (GRDX) | 4/1/2025 5:22:04 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $85,409,506 | EPS -$5.33 | ||
| Entero Therapeutics, Inc. (GRDX) | 11/13/2024 7:32:52 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $85,820,620 | EPS -$0.59 | ||
| Entero Therapeutics, Inc. (GRDX) | 10/21/2024 7:41:31 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $86,287,453 | EPS -$3.86 | ||
| First Wave BioPharma, Inc. (GRDX) | 5/14/2024 5:39:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $91,133,902 | EPS $0.38 | ||
| First Wave BioPharma, Inc. (GRDX) | 3/29/2024 4:27:15 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $6,883,195 | EPS -$47.88 | ||
| First Wave BioPharma, Inc. (GRDX) | 11/13/2023 4:27:35 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $5,927,269 | EPS -$9.21 | ||
| First Wave BioPharma, Inc. (GRDX) | 11/13/2023 4:24:51 PM | View | Proxy | SEC | Y 2022 | ||||||
| First Wave BioPharma, Inc. (GRDX) | 8/14/2023 4:29:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $4,327,871 | EPS -$37.73 | ||
| First Wave BioPharma, Inc. (GRDX) | 7/13/2023 7:15:52 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $4,327,871 | EPS -$37.73 | Export Earnings Model | ||
| First Wave BioPharma, Inc. (GRDX) | 5/15/2023 4:57:19 PM | View | Proxy | SEC | Y 2022 | ||||||
| First Wave BioPharma, Inc. (GRDX) | 5/12/2023 8:41:19 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $5,533,976 | EPS -$36.46 | ||
| First Wave BioPharma, Inc. (GRDX) | 3/20/2023 4:20:32 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $5,439,699 | EPS -$416.94 | ||
| First Wave BioPharma, Inc. (GRDX) | 12/16/2022 4:42:19 PM | View | Proxy | SEC | Y 2021 | ||||||
| First Wave BioPharma, Inc. (GRDX) | 11/14/2022 10:08:38 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $4,645,403 | EPS $18.23 | ||
| First Wave BioPharma, Inc. (GRDX) | 8/15/2022 8:57:15 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $3,927,274 | EPS -$53.47 | ||
| First Wave BioPharma, Inc. (GRDX) | 7/25/2022 5:29:40 PM | View | Proxy | SEC | Y 2021 | ||||||
| First Wave BioPharma, Inc. (GRDX) | 5/23/2022 9:38:15 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $8,825,439 | EPS -$138.28 | ||
| First Wave BioPharma, Inc. (GRDX) | 5/10/2022 4:49:31 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Assets $11,789,976 | EPS -$1,988.53 | ||
| First Wave BioPharma, Inc. (GRDX) | 3/31/2022 6:30:33 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $11,789,976 | EPS -$1,988.53 | ||
| First Wave BioPharma, Inc. (GRDX) | 11/19/2021 5:01:28 PM | View | Proxy | SEC | Y 2020 | ||||||
| First Wave BioPharma, Inc. (GRDX) | 11/16/2021 5:13:57 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2021 ending: 9/30/2021 | Assets $12,424,029 | EPS -$98.00 | ||
| AzurRx BioPharma, Inc. (GRDX) | 8/16/2021 4:51:59 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $13,776,799 | EPS -$1.63 | ||
| AzurRx BioPharma, Inc. (GRDX) | 5/24/2021 10:04:50 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $17,982,893 | EPS -$5.42 | ||
| AzurRx BioPharma, Inc. (GRDX) | 3/31/2021 5:35:49 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $12,923,855 | EPS -$14.68 | ||
| AzurRx BioPharma, Inc. (GRDX) | 1/19/2021 8:02:18 AM | View | Proxy | SEC | Y 2020 | ||||||
| AzurRx BioPharma, Inc. (GRDX) | 11/16/2020 4:43:44 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $16,722,021 | EPS -$4.72 | ||
| AzurRx BioPharma, Inc. (GRDX) | 8/14/2020 4:45:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $6,861,788 | EPS -$0.17 | ||
| AzurRx BioPharma, Inc. (GRDX) | 8/11/2020 10:09:00 AM | View | Proxy | SEC | Y 2019 | ||||||
| AzurRx BioPharma, Inc. (GRDX) | 8/7/2020 4:44:19 PM | View | Proxy | SEC | Y 2019 | ||||||
| AzurRx BioPharma, Inc. (GRDX) | 5/15/2020 4:45:52 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $8,184,312 | EPS -$0.20 | ||
| AzurRx BioPharma, Inc. (GRDX) | 3/30/2020 5:35:43 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $8,902,880 | EPS $22,425,564.00 | ||
| AzurRx BioPharma, Inc. (GRDX) | 11/14/2019 5:26:57 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $9,435,723 | EPS -$0.17 | ||
| AzurRx BioPharma, Inc. (GRDX) | 11/7/2019 4:00:49 PM | View | Proxy | SEC | Y 2018 | ||||||
| AzurRx BioPharma, Inc. (GRDX) | 8/13/2019 6:15:27 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $9,612,406 | EPS -$0.25 | ||
| AzurRx BioPharma, Inc. (GRDX) | 5/15/2019 5:51:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $8,956,510 | EPS -$0.26 | ||
| AzurRx BioPharma, Inc. (GRDX) | 4/1/2019 5:02:31 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $7,469,395 | EPS $15,439,310.00 | ||
| AzurRx BioPharma, Inc. (GRDX) | 11/9/2018 4:55:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $8,578,368 | EPS -$0.15 | ||
| AzurRx BioPharma, Inc. (GRDX) | 8/13/2018 6:17:06 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $11,739,238 | EPS -$0.22 | ||
| AzurRx BioPharma, Inc. (GRDX) | 7/23/2018 5:07:34 PM | View | Proxy | SEC | Y 2017 | ||||||
| AzurRx BioPharma, Inc. (GRDX) | 5/14/2018 5:29:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $10,000 | Assets $5,247,946 | EPS -$0.29 | |
| AzurRx BioPharma, Inc. (GRDX) | 3/16/2018 5:17:03 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $5,479,668 | EPS -$1.04 | ||
| AzurRx BioPharma, Inc. (GRDX) | 11/13/2017 4:56:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $250,000 | Assets $6,836,368 | EPS -$0.28 | |
| AzurRx BioPharma, Inc. (GRDX) | 10/19/2017 8:27:18 PM | View | Proxy | SEC | Y 2016 | ||||||
| AzurRx BioPharma, Inc. (GRDX) | 8/14/2017 3:59:43 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $8,764,296 | EPS -$0.27 | ||
| AzurRx BioPharma, Inc. (GRDX) | 5/15/2017 6:16:07 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $5,423,740 | EPS -$0.29 | ||
| AzurRx BioPharma, Inc. (GRDX) | 3/31/2017 4:16:20 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $300,000 | Assets $6,753,842 | EPS -$2.24 | |
| AzurRx BioPharma, Inc. (GRDX) | 11/25/2016 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $5,585,765 | EPS -$0.53 |